What is the current Price Target for the Xenon Pharmaceuticals Inc. stock?

The average Xenon Pharmaceuticals Inc. target price is $81.60. This is 114.40% higher than the current stock price. The highest price target is 175.88%, the lowest is 83.11%. 20 Analysts have issued a price target Xenon Pharmaceuticals Inc. 2027 .

How high will the Xenon Pharmaceuticals Inc. stock rise?

No reliable answer can be given as to how high the Xenon Pharmaceuticals Inc. stock will rise. The performance of stocks, including the Xenon Pharmaceuticals Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Xenon Pharmaceuticals Inc. stock today?

The performance of Xenon Pharmaceuticals Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Xenon Pharmaceuticals Inc. stock fall?

The decline in Xenon Pharmaceuticals Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Xenon Pharmaceuticals Inc. Forecast, price target & analysts

$38.06

0.01%

Nasdaq, Sep 25, 09:33 am EDT. Market open.

ISIN

CA98420N1050

Symbol

XENE

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Analysts Charts Ownership News Strategies

Xenon Pharmaceuticals Inc. Target price 2026 - Analyst rating & recommendation

Xenon Pharmaceuticals Inc. Classifications & Recommendation

Buy

96%

Hold

Xenon Pharmaceuticals Inc. Price Target

Target Price	$81.60
Price	$38.06
Potential	114.40% register free of charge
Number of Estimates	20

	20 Analysts have issued a price target Xenon Pharmaceuticals Inc. 2027 . The average Xenon Pharmaceuticals Inc. target price is $81.60. This is 114.40% register free of charge higher than the current stock price. The highest price target is $105.00 175.88% register free of charge , the lowest is $69.69 83.11% register free of charge .
	A rating was issued by 26 analysts: 25 Analysts recommend Xenon Pharmaceuticals Inc. to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Xenon Pharmaceuticals Inc. stock has an average upside potential 2027 of 114.40% register free of charge . Most analysts recommend the Xenon Pharmaceuticals Inc. stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '25	2026 Estimates
Earnings Per Share $	-4.36	-4.71
	44.85%	8.03%
P/E		negative
EV/Sales		1,860.37

22 Analysts have issued a Xenon Pharmaceuticals Inc. forecast for earnings per share. The average Xenon Pharmaceuticals Inc. EPS is

unlock

. This is

unlock

than earnings per share in the financial year 2025. The highest EPS forecast is

unlock

, the lowest is

unlock

This results in the following potential growth metrics and future valuations:

2025	$-4.36	44.85%
2026	$-4.71 8.03% unlock
2027	$-4.82 2.34% unlock
2028	$-3.84 20.33% unlock
2029	$-0.81 78.91% unlock
2030	$2.36 391.36% unlock
2031	$5.18 119.49% unlock
2032	$7.95 53.47% unlock
2033	$10.69 34.47% unlock

Current	-9.28	11.07%
2026	-8.09 12.85% unlock
2027	-7.89 2.47% unlock
2028	-9.92 25.73% unlock
2029	-46.75 371.27% unlock
2030	16.12 134.48% unlock
2031	7.35 54.40% unlock
2032	4.79 34.83% unlock
2033	3.56 25.68% unlock

Xenon Pharmaceuticals Inc....

Current Xenon Pharmaceuticals Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Needham	Locked ➜ Locked	Locked	Sep 18 2026
Baird	Locked ➜ Locked	Locked	Sep 18 2026
Wedbush	Locked ➜ Locked	Locked	Sep 18 2026
Wells Fargo	Locked ➜ Locked	Locked	Sep 18 2026
Deutsche Bank	Locked ➜ Locked	Locked	Sep 18 2026
RBC Capital	Locked ➜ Locked	Locked	Sep 18 2026
RBC Capital	Locked ➜ Locked	Locked	Aug 07 2026

Analyst Rating	Date
Locked Needham: Locked ➜ Locked	Sep 18 2026
Locked Baird: Locked ➜ Locked	Sep 18 2026
Locked Wedbush: Locked ➜ Locked	Sep 18 2026
Locked Wells Fargo: Locked ➜ Locked	Sep 18 2026
Locked Deutsche Bank: Locked ➜ Locked	Sep 18 2026
Locked RBC Capital: Locked ➜ Locked	Sep 18 2026
Locked RBC Capital: Locked ➜ Locked	Aug 07 2026

Discover more stocks with a high price target

NIO ADR 101.75%

Alibaba Group Holding Ltd 70.15%

Tencent Holdings Ltd. 56.53%

Uber Technologies 48.83%

Siemens Energy 47.15%

BYD 47.08%

Adidas 46.64%

Deutsche Telekom 38.45%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now